BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, January 31, 2025
Breaking News: BioWorld by Clarivate releases comprehensive 2024 year in review
See today's BioWorld Science
Home
» CD5-knockout anti-CD5 CAR T-cell product evaluated for relapsed and refractory CD5+ nodal T-cell lymphomas
To read the full story,
subscribe
or
sign in
.
Cancer
CD5-knockout anti-CD5 CAR T-cell product evaluated for relapsed and refractory CD5+ nodal T-cell lymphomas
Jan. 12, 2023
No Comments
The relative 5-year survival for Non-Hodgkin...
BioWorld Science
Conferences
CAR T
Cancer
CAR T